Hepatotoxicity of halogenated inhalational anesthetics

Iranian Red Crescent Medical Journal

Volumn 16, Issue 9, 2014, Pages

  Safari, Saeid ^a   Motavaf, Mahsa ^b,c   Siamdoust, Seyed Alireza Seyed ^a   Alavian, Seyed Moayed ^c,d  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

^c Middle East Liver Diseases Center (MELD Centers)   (Iran)

^d BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anesthesiology; Halothane; Inhalation anesthesia; Liver injury drug induced; Sevoflurane

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; ASPARTATE AMINOTRANSFERASE; CYTOCHROME P450 2E1; DESFLURANE; ENFLURANE; HALIDE; HALOTHANE; HEXAFLUORO 2 PROPANOL; IMMUNOGLOBULIN G; INHALATION ANESTHETIC AGENT; ISOFLURANE; PHENOTHIAZINE DERIVATIVE; PHENYTOIN; SEVOFLURANE;

BIOTRANSFORMATION; CHRONIC LIVER DISEASE; DRUG METABOLISM; DRUG PROTEIN BINDING; HEMOLYSIS; HEPATITIS; HUMAN; HYPOXIA; IMMUNE RESPONSE; INCIDENCE; JAUNDICE; LIVER FUNCTION; LIVER INJURY; LIVER NECROSIS; LIVER TOXICITY; REPERFUSION INJURY; REVIEW;

EID: 84921982591     PISSN: 20741804     EISSN: 20741812     Source Type: Journal    
DOI: 10.5812/ircmj.20153     Document Type: Review

References (50)

1. Zimmerman HJ. Hepatotoxicity: The adverse effects of drugs and other chemicals on the liver: Lippincott Williams and Wilkins; 1999.
2. Weber LW, Boll M, Stampfl A. Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Crit Rev Toxicol. 2003;33(2):105-36.
3. Sinha A, Clatch RJ, Stuck G, Blumenthal SA, Patel SA. Isoflurane hepatotoxicity: a case report and review of the literature. Am J Gastroenterol. 1996;91(11):2406-9.
4. Singhal S, Gray T, Guzman G, Verma A, Anand K. Sevoflurane hepatotoxicity: a case report of sevoflurane hepatic necrosis and review of the literature. Am J Ther. 2010;17(2):219-22.
5. Fee JP, Thompson GH. Comparative tolerability profiles of the inhaled anaesthetics. Drug Saf. 1997;16(3):157-70.
6. National Research Council (U.S.) Subcommittee on the National Halothane Study. The national halothane study: A study of the possible association between halothane anesthesia and postoperative hepatic necrosis; report: National Academies; 1969.
7. Mahboobi N, Esmaeili S, Safari S, Habibollahi P, Dabbagh A, Alavian SM. Halothane: how should it be used in a developing country? East Mediterr Health J. 2012;18(2):159-64.
8. Dabbagh A, Rajaei S. The role of anesthetic drugs in liver apoptosis. Hepat Mon. 2013;13(8).
9. Wright R, Eade OE, Chisholm M, Hawksley M, Lloyd B, Moles TM, et al. Controlled prospective study of the effect on liver function of multiple exposures to halothane. Lancet. 1975;1(7911):817-20.
10. Pandit A, Sachdeva T, Bafna P. Drug-induced hepatotoxicity: A review. J Appl Pharm Sc. 2012;2(5).
11. Dabbagh A, Rajaei S. Halothane: Is there still any place for using the gas as an anesthetic? Hepat Mon. 2011;11(7):511-2.
12. Mushin WW, Rosen M, Jones EV. Post-halothane jaundice in relation to previous administration of halothane. Br Med J. 1971;3(5765):18-22.
13. Inman WH, Mushin WW. Jaundice after repeated exposure to halothane: a further analysis of reports to the Committee on Safety of Medicines. Br Med J. 1978;2(6150):1455-6.
14. Moult PJ, Sherlock S. Halothane-related hepatitis. A clinical study of twenty-six cases. Q J Med. 1975;44(173):99-114.
15. Habibollahi P, Mahboobi N, Esmaeili S, Safari S, Dabbagh A, Alavian SM. Halothane-induced hepatitis: A forgotten issue in developing countries: Halothane-induced hepatitis. Hepat Mon. 2011;11(1):3-6.
16. Gut J, Christen U, Huwyler J. Mechanisms of halothane toxicity: Novel insights. Pharmacol Ther. 1993;58(2):133-55.
17. Dienstag JL. Halothans hepatitis: Allergy or idiosyncrasy? N Engl J Med. 1980;303(2):102-4.
18. Kenna JG, Satoh H, Christ DD, Pohl LR. Metabolic basis for a drug hypersensitivity: antibodies in sera from patients with halo­thane hepatitis recognize liver neoantigens that contain the trifluoroacetyl group derived from halothane. J Pharmacol Exp Ther. 1988;245(3):1103-9.
19. Reichle FM, Conzen PF. Halogenated inhalational anaesthetics. Best Pract Res Clin Anaesthesiol. 2003;17(1):29-46.
20. Neuberger JM. Halothane and hepatitis. Incidence, predisposing factors and exposure guidelines. Drug Saf. 1990;5(1):28-38.
21. Cousins MJ, Plummer JL, Hall PD. Risk factors for halothane hepatitis. Aust N Z J Surg. 1989;59(1):5-14.
22. Stoelting RK, Hillier SC. Pharmacology and physiology in anesthetic practice: Lippincott Williams and Wilkins; 2012.
23. Fuhrmann V, Jager B, Zubkova A, Drolz A. Hypoxic hepatitis - epidemiology, pathophysiology and clinical management. Wien Klin Wochenschr. 2010;122(5-6):129-39.
24. Haseli N, Hassanzadeh J, Dehghani SM, Bahador A, Malek Hosseini SA. Long-term survival and its related factors in pediatric liver transplant recipients of shiraz transplant center, shiraz, iran in 2012. Hepat Mon. 2013;13(7): e10257.
25. Lewis JH, Zimmerman HJ, Ishak KG, Mullick FG. Enflurane hepatotoxicity. A clinicopathologic study of 24 cases. Ann Intern Med. 1983;98(6):984-92.
26. Njoku D, Laster MJ, Gong DH, Eger EI, Reed GF, Martin JL. Biotrans­formation of halothane, enflurane, isoflurane, and desflurane to trifluoroacetylated liver proteins: association between protein acylation and hepatic injury. Anesth Analg. 1997;84(1):173-8.
27. Khajavi M, Emami A, Etezadi F, Safari S, Sharifi A, Shariat Moharari R. Conscious Sedation and Analgesia in Colonoscopy: Ketamine/ Propofol Combination has Superior Patient Satisfaction Versus Fentanyl/Propofol. Anesth Pain Med. 2013;3(1):208-13.
28. Weitz J, Kienle P, Bohrer H, Hofmann W, Theilmann L, Otto G. Fatal hepatic necrosis after isoflurane anaesthesia. Anaesthesia. 1997;52(9):892-5.
29. Ihtiyar E, Algin C, Haciolu A, Isiksoy S. Fatal isoflurane hepatotoxicity without re-exposure. Indian J Gastroenterol. 2006; 25(1):41-2.
30. Anderson JS, Rose NR, Martin JL, Eger EI, Njoku DB. Desflurane hepatitis associated with hapten and autoantigen-specific IgG4 antibodies. Anesth Analg. 2007;104(6):1452-3.
31. Katz J, Magee J, Baker B, Eger EI, 2nd. Hepatic necrosis associated with herpesvirus after anesthesia with desflurane and nitrous oxide. Anesth Analg. 1994;78(6):1173-6.
32. Tung D, Yoshida EM, Wang CS, Steinbrecher UP. Severe desflurane hepatotoxicity after colon surgery in an elderly patient. Can J Anaesth. 2005;52(2):133-6.
33. Berghaus TM, Baron A, Geier A, Lamerz R, Paumgartner G. Hepatotoxicity following desflurane anesthesia. Hepatology. 1999;29(2):613-4.
34. Eydi M, Golzari SE, Aghamohammadi D, Kolahdouzan K, Safari S, Ostadi Z. Postoperative Management of Shivering: A Comparison of Pethidine vs. Ketamine. Anesth Pain Med. 2014;4(2).
35. Hajiesmaeili MR, Motavaf M, Safari S. Regional analgesia in intensive care unit. Anesth Pain Med. 2013;3(2):263-5.
36. Bito H, Ikeda K. Renal and hepatic function in surgical patients after low-flow sevoflurane or isoflurane anesthesia. Anesth Analg. 1996;82(1):173-6.
37. Frink EJ Jr. The hepatic effects of sevoflurane. Anesth Analg. 1995;81(6 Suppl):S46-50.
38. Kharasch ED, Karol MD, Lanni C, Sawchuk R. Clinical sevoflurane metabolism and disposition. I. Sevoflurane and metabolite pharmacokinetics. Anesthesiology. 1995;82(6):1369-78.
39. Ni J, Sato N, Fujii K, Yuge O. Urinary excretion of hexafluoroisopropanol glucuronide and fluoride in patients after sevoflurane anaesthesia. J Pharm Pharmacol. 1993;45(1):67-9.
40. Clavien PA, Selzner M, Rudiger HA, Graf R, Kadry Z, Rousson V, et al. A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg. 2003;238(6):843-50.
41. Rehder K, Forbes J, Alter H, Hessler O, Stier A. Halothane bio­transformation in man: a quantitative study. Anesthesiology. 1967;28(4):711-5.
42. Movasseghi G, Hassani V, Mohaghegh MR, Safaeian R, Safari S, Zamani MM, et al. Comparison between spinal and general anesthesia in percutaneous nephrolithotomy. Anesth Pain Med. 2014;4(1).
43. Pouraghaei M, Moharamzadeh P, Soleimanpour H, Rahmani F, Safari S, Mahmoodpoor A, et al. Comparison between the effects of alfentanil, fentanyl and sufentanil on hemodynamic indices during rapid sequence intubation in the emergency department. Anesth Pain Med. 2014;4(1).
44. Watanabe K, Hatakenaka S, Ikemune K, Chigyo Y, Kubozono T, Arai T. [A case of suspected liver dysfunction induced by sevoflurane anesthesia]. Masui. 1993;42(6):902-5.
45. Eger EI, 2nd, Koblin DD, Bowland T, Ionescu P, Laster MJ, Fang Z, et al. Nephrotoxicity of sevoflurane versus desflurane anesthesia in volunteers. Anesth Analg. 1997;84(1):160-8.
46. Rahimzadeh P, Safari S, Faiz SH, Alavian SM. Anesthesia for patients with liver disease. Hepat Mon. 2014;14(7): e19881.
47. Mohseni M, Safari S, Alavian SM. Volatile anesthetics in ischemic liver injury: enemy or friend? Hepat Mon. 2014;14(6):e19880.
48. Hassani V, Movassaghi G, Goodarzi V, Safari S. Comparison of fentanyl and fentanyl plus lidocaine on attenuation of hemodynamic responses to tracheal intubation in controlled hypertensive patients undergoing general anesthesia. Anesth Pain Med. 2013;2(3):115-8.
49. Bedirli N, Ofluoglu E, Kerem M, Utebey G, Alper M, Yilmazer D, et al. Hepatic energy metabolism and the differential protective effects of sevoflurane and isoflurane anesthesia in a rat hepatic ischemia-reperfusion injury model. Anesth Analg. 2008;106(3):830-7.
50. Zhou SP, Jiang P, Liu L, Liu H. Protective effect of sevoflurane on hepatic ischaemia/reperfusion injury in the rat: A dose-response study. Eur J Anaesthesiol. 2013.